Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations

Part of paid clinical trials in Gainesville, Florida.

Sponsor
University of Florida
Study ID
NCT07581379
Status
Active Not Recruiting

Conditions

  • Lung Cancer (Diagnosis)
  • Lung Neoplasms
  • Non-Small Cell Lung Cancer (NSCLC), Stage I-IIIA
  • Second Primary Lung Cancer (SPLC)

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This observational study evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population. The main questions are: How do CT surveillance use and adherence vary by race, ethnicity, and socioeconomic status? Does semi-annual CT surveillance improve outcomes compared with annual surveillance? Adults ages 20-90 with stage I-IIIA NSCLC treated between 2012 and 2026 will be identified using OneFlorida+ electronic health records, tumor registry data, claims, and clinical notes. Patients will be followed for up to five years after curative-intent therapy to evaluate surveillance patterns, recurrence, second primary lung cancers, complications, and survival.

Key Dates

Start date
Jan 31, 2012
Status verified
Jan 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
1,826 participants (actual)

Arms

  • Arm: Target population includes confirmed stage I-IIIA NSCLC patients within the OneFlorida+ Consortium

Primary Outcome Measure

Guideline Adherence to Chest CT Surveillance [ Time Frame: Up to 5 years after treatment completion ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Florida College of MedicineGainesvilleFlorida32610-

Find similar trials in Gainesville, FL

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
University of Florida College of Medicine· Gainesville, FL

Related Studies